Collagen Solutions Share Discussion Threads

[moontheloon] 27/8/2020 15:28

I said more than likely rosen... And my 100k addition I bought just before takeover announcement now looking sweet at 1.2p . Good luck all and well done patient holders

[timbo003] 27/8/2020 15:03

It was always obvious (at least to me) that any offer would have to be at least 5p/share, as that was the price stumped up by investors for the last two funding rounds, accordingly I have been buying in dribs and drabs over the last few weeks, including 50K earlier this morning. How lucky was that 🤑

[csmwssk12hu] 27/8/2020 14:51

Well done great news for holders maybe MSYS is next!

[18bt] 21/7/2020 07:57

Nice one - seems to be building a head of steam in sales - albeit from a low base.

[wapper] 21/7/2020 07:19

Great announcement. Good luck everyone in here

[moontheloon] 21/7/2020 07:10

Should get us going well today and ongoing.. Need news on ce mark and takeover too to add to this, the story of all that potential in this company is beginnning to unfold. But share price rising in meantime bumps up any takeover price. IMHO. Good luck all

[moontheloon] 21/7/2020 07:06

21 July 2020Collagen Solutions Plc(the "Company") Trading UpdateNew contract win enhances revenues Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces an update to its order book/contracted development revenues following the signing of a significant new contract.The Company has performed well, and has recently finalised  a number of contracts, including the Novabone supply agreement announced on 7 July and a new supply agreement with an existing client for a long-term supply with larger contracted volumes as at 15 July 2020. With the new contract in place, the Company now has orders or contracted development milestones for FY 2021, together with revenue already recognised through the first three months of the financial year, worth approximately £4.3m (representing 108% of the sales in the last financial year). Jamal Rushdy, CEO of Collagen Solutions said: "We are delighted to have secured this new contract. In our trading update announced in June, we said our order book was at approximately £3.3m, which was 82% of FY 2020 revenue. This further strengthening of the order book now puts us in a strong position to deliver a successful financial year. We remain confident that we can generate value to shareholders over the medium term."Collagen Solutions PlcD:  [phone]M: [phone]  

[moontheloon] 09/7/2020 14:05

Strange that apparent selling after news maybe short termers taking profit waiting for news of takeover... Takeover or not business going in right direction... Chondromimetic ce mark gotta be anytime soon which will get it moving a pace

[plasybryn] 07/7/2020 08:07

Nice news this morning.

[18bt] 19/5/2020 16:51

I think they will only get a multiple of the current share price if they can get a competition between 2 buyers or have serious financing offers which allow them to turn down anything. Timing is not ideal as all involved need to look through COVID.

[plasybryn] 19/5/2020 11:52

Thanks. Helpful reply. If true I can see quite a bit more upside yet leading to a possible bid, once the market wakes up to what is going on here.

[moontheloon] 19/5/2020 09:50

I think its hard to quantify chairman and directors and other large shareholders will def want more than 5p as last placing was that amount, with the company having the chondromimetic on the market globally, its proven over more years than other methods cheaper, faster, less invasive no brainer that this will be take a healthy market share for knee surgery/complaints. Id say 8p-15p on reflection. Although thry may go large partner investment route, i think rosen will buy it as its their market and already involved. All imho

[plasybryn] 18/5/2020 18:19

So how much is the business worth if a bid is received. Any idea?

[moontheloon] 18/5/2020 07:27

Collagen Solutions plc(the "Company") Strategic Review and Formal Sale Process Update Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, is providing an update on the Company's strategic review and formal sale process and receipt of multiple indications of interest. On 16 April 2020, the Company announced that following receipts of interest it decided to conduct a formal review of various strategic options available to the Company to maximise value for shareholders. These options included, but were not limited to, the potential sale of the Company or the sale of one or more of the Company's assets. To facilitate discussions with interested parties the Company announced the commencement of a "formal sale process" as set out by the Takeover Code.  As part of the formal sale process or the sale of one of more of the Company's assets, parties were requested to submit an indication of interest to the Company's financial advisers by no later than 5.00 p.m. (London time) on 15 May 2020. The Company has received indications of interest in respect of (i) a purchase of the Company as a whole (ii) a purchase or investment in a part of the business of the Company and (iii) a refinancing of the Company. The Company looks forward to engaging with relevant parties in a constructive and positive manner with a view to optimising value for shareholders.There can be no certainty that an offer will be made, nor as to the terms on which any offer will be made, or that any transaction will ensue. 

[moontheloon] 22/4/2020 19:17

And now rosen, my monies on them becoming new owners as they already have vested interest. Watch this space.

[moontheloon] 17/4/2020 16:12

Thats 3 parties disclosing interest in the company whilst being party to an offer in the offer process. So potentially.. so far, 3 parties competing for collagen solutions. Which makes it interesting!FyiFORMS 8.3 AND 8.5Home > Investing > Terms Glossary > Forms 8.3 and 8.5Forms 8.3 and 8.5 are disclosure forms required by the Takeover Panel to clarify material interests in the share register of a UK-listed company that is in a bid situation. Any person or institution that has an interest of more than 1% of the share capital of a company in a bid situation (on both sides of the transaction) must disclose any dealings in those shares and their resultant position.Form 8.3 should be completed by the shareholder to clarify what they have bought or sold and the resultant size of their stake. Form 8.5, meanwhile, should be completed by any principal trader that has dealt in the shares.These disclosure forms are required as part of the Takeover Code which aims to ensure an orderly framework within which takeovers can be conducted fairly and appropriately.

[moontheloon] 16/4/2020 10:57

What we thinking non doldrums offer price taking into account new income streams due and market leading, low invasive, cheaper, medical outcome proven knee treatment? And to make big holders like evans happy? Which is what ultimately will happen.Im thinking 20p+ mark

[moontheloon] 16/4/2020 08:30

Glad i got another 100k shares early yesterday in newly transferred sipp!. There was always going to be tight cash issue but for a bigger pharma to swallow up the rights for chondro as it approaches finalisation is absolute no brainer. Needs a partnership funding, or a sale as long as shareholders get good value I'm happy. Good luck all

[zen12] 16/4/2020 08:18

Not one but number of parties interested, could see a bidding war..The Company confirms that, at the time of this announcement, it is in discussions with a number of parties regarding a potential sale of the Company.

[gwr7] 16/4/2020 07:58

Not surprising a few fancy their chances of running the company better than the current cretins.

[pugugly] 03/4/2020 11:48

Melt down - Shares being dumped below 0.8p Anyone sure of the debt position?